6月13日，Palantir盘中下跌3.23%，报126.85美元/股，成交额19.83亿美元。
消息面上，英国政府正对Palantir与国家医疗服务体系（NHS）签订的价值3.3亿英镑（约4.41亿美元）合同展开全面审查。英国下议院科学、创新与技术委员会将Palantir描述为公共部门中"不可接受的风险点"，并敦促政府在合同于2027年初到期时启用解约条款。该合同还因Palantir同时服务于美国军方及移民执法机构而受到额外审视。此外，公司CEO卡普近日表示企业客户对前沿AI实验室普遍不满，叠加此前知名空头迈克尔·伯里公开唱空，估值争议持续发酵，多重利空共振压制股价。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.